Loading...
Loading...
India accounts for a significant share of global Itraconazole exports, with 285+ registered manufacturers shipping to buyers across 123+ countries β yet a handful of companies dominate the shipments. CAPLIN POINT LABORATORIES LIMITED holds the largest share at 11.0% (export value: $3.0M). Close behind, COHANCE LIFESCIENCES LIMITED (9.2%, $2.5M). ANNORA PHARMA PRIVATE LIMITED (7.9%, $2.2M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.

Comprehensive supplier network intelligence dashboard
Flow of Itraconazole from leading Indian exporters to their key global customers
Top Suppliers β Customer Networks
The Itraconazole export market from India is led by CAPLIN POINT LABORATORIES LIMITED, which alone commands a 11.0% share, shipping $3.0M worth of product across 10 shipments. The second-largest exporter, COHANCE LIFESCIENCES LIMITED, contributes $2.5M (9.2%) to the overall market. Combined, the top two suppliers alone account for 20.1% of all Itraconazole exports, indicating a relatively concentrated supply base.
Across all 285 tracked manufacturers, the total Itraconazole export value stands at $27.4M from 2.7K shipments. The market average shipment value is $10.0K. The single largest buyer relationship in terms of trade value is NEOETHICALS, S.A,, receiving $2.0M worth of product.
The combined buyer network spans 16 named purchasing companies, including NEOETHICALS, S.A,, NEOETHICALS CIA LTDA, NUEVOS ETICOS NEOETH, NOVAMED FABRICACAO DE PRODUCTOS, ARROW PHARMACEUTICAL and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
CAPLIN POINT LABORATORIES LIMITED is the first-largest Itraconazole exporter from India, with a market share of 11.0% and a total export value of $3.0M across 10 shipments. Their average shipment value of $299.8K is above the market average of $10.0K, suggesting premium or bulk contract pricing.
CAPLIN POINT LABORATORIES LIMITED serves 4 named buyers in our database. NEOETHICALS, S.A, is the dominant customer, accounting for 68.3% of this supplier's tracked business. Top customers include:
β’ NEOETHICALS, S.A, β $2.0M across 7 shipments (68.3% of this supplier's total exports)
β’ NEOETHICALS CIA LTDA β $880.4K across 3 shipments (29.4% of this supplier's total exports)
β’ NUEVOS ETICOS NEOETH β $42.5K across 0 shipments (1.4% of this supplier's total exports)
β’ NUEVOS ETICOS NEOETH β $28.1K across 0 shipments (0.9% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $299.8K is 2887% above the market average of $10.0K, consistent with large-order contracts or value-added formulations.
COHANCE LIFESCIENCES LIMITED is the second-largest Itraconazole exporter from India, with a market share of 9.2% and a total export value of across . Their average shipment value of is
Once Itraconazole leaves the manufacturing plants of companies like CAPLIN POINT LABORATORIES LIMITED and COHANCE LIFESCIENCES LIMITED, it travels to 5 destination markets with a combined import value of $27.4M. United States absorbs the largest share at 33.5% ($9.2M), followed by Brazil (8.9%) and Nicaragua (7.5%).
In United States β the top destination β named importers include AMNEAL PHARMACEUTICALS, LLC (KY), ASCEND LABORATORIES,LLC, AMNEAL PHARMACEUTICALS LLC KY. In Brazil, key buyers are NOVAMED FABRICACAO DE PRODUTOS, NOVAMED FABRICACAO DE PRODUCTOS.
This geographic spread reflects Itraconazole's role as an essential active pharmaceutical ingredient (API) and finished dosage form β sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Itraconazole exports from India β top destination countries and the named companies importing it
Top Countries β Global Importers
United States ranks as the first-largest destination for Itraconazole imports from India, with a total trade value of $9.2M across 85 shipments β representing a 33.5% share of all Itraconazole exports. The average shipment value of $107.9K is above the global average of $10.0K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Itraconazole importers in United States: AMNEAL PHARMACEUTICALS, LLC (KY) is the largest buyer, accounting for 15.3% ($1.4M) of this market's total imports.
β’ AMNEAL PHARMACEUTICALS, LLC (KY) β $1.4M (15.3% of United States's total)
β’ ASCEND LABORATORIES,LLC β $998.1K (10.9% of United States's total)
β’ AMNEAL PHARMACEUTICALS LLC KY β $707.1K (7.7% of United States's total)
Key Insight: United States's per-shipment average of $107.9K (975% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Itraconazole imports from India.
Visual overview of India's itraconazole supply chain network β top suppliers, destinations, pricing, and trade routes
This video covers India's itraconazole pharmaceutical supply chain network β $27.4M in total trade, 123 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.
Latest developments and market context
Detailed market intelligence for Itraconazole β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
COHANCE LIFESCIENCES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
β’ NOVAMED FABRICACAO DE PRODUCTOS β $980.7K across 27 shipments (39.0% of this supplier's total exports)
β’ NOVAMED FABRICACAO DE PRODUCTOS β $587.0K across 16 shipments (23.4% of this supplier's total exports)
β’ ARROW PHARMACEUTICAL β $337.0K across 9 shipments (13.4% of this supplier's total exports)
β’ ARROW PHARMACEUTICAL β $314.2K across 9 shipments (12.5% of this supplier's total exports)
β’ MINT PHARMACEUTICALS INC. β $294.1K across 8 shipments (11.7% of this supplier's total exports)
Key Insight: COHANCE LIFESCIENCES LIMITED's per-shipment value of $36.4K is 263% above the market average of $10.0K, consistent with large-order contracts or value-added formulations.
ANNORA PHARMA PRIVATE LIMITED is the third-largest Itraconazole exporter from India, with a market share of 7.9% and a total export value of $2.2M across 27 shipments. Their average shipment value of $79.9K is above the market average of $10.0K, suggesting premium or bulk contract pricing.
ANNORA PHARMA PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
β’ TO THE ORDER OF. β $715.1K across 9 shipments (33.1% of this supplier's total exports)
β’ TO THE ORDER OF. β $691.3K across 9 shipments (32.0% of this supplier's total exports)
β’ CAMBER PHARMACEUTICALS INC β $545.4K across 7 shipments (25.3% of this supplier's total exports)
β’ M/S. β $206.1K across 3 shipments (9.6% of this supplier's total exports)
Key Insight: ANNORA PHARMA PRIVATE LIMITED's per-shipment value of $79.9K is 696% above the market average of $10.0K, consistent with large-order contracts or value-added formulations.
AMNEAL PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Itraconazole exporter from India, with a market share of 6.2% and a total export value of $1.7M across 38 shipments. Their average shipment value of $44.8K is above the market average of $10.0K, suggesting premium or bulk contract pricing.
AMNEAL PHARMACEUTICALS PRIVATE LIMITED serves 4 named buyers in our database. AMNEAL PHARMACEUTICALS LLC KY is the dominant customer, accounting for 56.3% of this supplier's tracked business. Top customers include:
β’ AMNEAL PHARMACEUTICALS LLC KY β $957.8K across 21 shipments (56.3% of this supplier's total exports)
β’ AMNEAL PHARMACEUTICALS LLC KY β $556.1K across 12 shipments (32.7% of this supplier's total exports)
β’ AMNEAL PHARMACEUTICALS LLC KY β $151.0K across 3 shipments (8.9% of this supplier's total exports)
β’ AMNEAL PHARMACEUTICALS LLC KY β $37.4K across 1 shipments (2.2% of this supplier's total exports)
Key Insight: AMNEAL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $44.8K is 346% above the market average of $10.0K, consistent with large-order contracts or value-added formulations.
MICRO LABS LIMITED is the fifth-largest Itraconazole exporter from India, with a market share of 6.1% and a total export value of $1.7M across 128 shipments. Their average shipment value of $12.9K is above the market average of $10.0K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
β’ MICRO HEALTHCARE PRIVATE LIMITED β $618.8K across 48 shipments (37.3% of this supplier's total exports)
β’ MICRO HEALTHCARE PRIVATE LIMITED β $577.9K across 45 shipments (34.9% of this supplier's total exports)
β’ MICRO NOVA PHARMACEUTICALS IND β $320.7K across 25 shipments (19.4% of this supplier's total exports)
β’ VIET NAM CHEMICO-PHA β $76.4K across 6 shipments (4.6% of this supplier's total exports)
β’ CENTRAL PHARMACEUTIC β $63.2K across 5 shipments (3.8% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $12.9K is 29% above the market average of $10.0K, consistent with large-order contracts or value-added formulations.
ALKEM LABORATORIES LIMITED is the fifth-largest Itraconazole exporter from India, with a market share of 5.6% and a total export value of $1.5M across 30 shipments. Their average shipment value of $50.9K is above the market average of $10.0K, suggesting premium or bulk contract pricing.
ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. ASCEND LABORATORIES,LLC is the dominant customer, accounting for 51.9% of this supplier's tracked business. Top customers include:
β’ ASCEND LABORATORIES,LLC β $793.1K across 16 shipments (51.9% of this supplier's total exports)
β’ ASCEND LABORATORIES,LLC β $338.8K across 7 shipments (22.2% of this supplier's total exports)
β’ AL MANARAH MEDICINE β $248.1K across 5 shipments (16.2% of this supplier's total exports)
β’ ASCEND LABORATORIES LLC β $118.1K across 2 shipments (7.7% of this supplier's total exports)
β’ ASCEND LABORATORIES LLC β $28.8K across 1 shipments (1.9% of this supplier's total exports)
Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $50.9K is 407% above the market average of $10.0K, consistent with large-order contracts or value-added formulations.
Brazil ranks as the second-largest destination for Itraconazole imports from India, with a total trade value of $2.4M across 23 shipments β representing a 8.9% share of all Itraconazole exports. The average shipment value of $105.7K is above the global average of $10.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Itraconazole importers in Brazil: NOVAMED FABRICACAO DE PRODUTOS is the largest buyer, accounting for 64.8% ($1.6M) of this market's total imports.
β’ NOVAMED FABRICACAO DE PRODUTOS β $1.6M (64.8% of Brazil's total)
β’ NOVAMED FABRICACAO DE PRODUCTOS β $587.0K (24.2% of Brazil's total)
Key Insight: Brazil's per-shipment average of $105.7K (953% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Itraconazole imports from India.
Nicaragua ranks as the third-largest destination for Itraconazole imports from India, with a total trade value of $2.1M across 3 shipments β representing a 7.5% share of all Itraconazole exports. The average shipment value of $686.4K is above the global average of $10.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Itraconazole importers in Nicaragua: NEOETHICALS, S.A, is the largest buyer, accounting for 100.0% ($2.1M) of this market's total imports.
β’ NEOETHICALS, S.A, β $2.1M (100.0% of Nicaragua's total)
Key Insight: Nicaragua's per-shipment average of $686.4K (6739% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nicaragua is a key market for Itraconazole imports from India.
Sri Lanka ranks as the fourth-largest destination for Itraconazole imports from India, with a total trade value of $1.7M across 18 shipments β representing a 6.3% share of all Itraconazole exports. The average shipment value of $95.8K is above the global average of $10.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Itraconazole importers in Sri Lanka: MICRO HEALTHCARE (PRIVATE) LIMITED is the largest buyer, accounting for 38.9% ($670.6K) of this market's total imports.
β’ MICRO HEALTHCARE (PRIVATE) LIMITED β $670.6K (38.9% of Sri Lanka's total)
β’ MICRO HEALTHCARE PRIVATE LIMITED β $618.8K (35.9% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $95.8K (854% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Itraconazole imports from India.
Switzerland ranks as the fifth-largest destination for Itraconazole imports from India, with a total trade value of $1.4M across 20 shipments β representing a 5.1% share of all Itraconazole exports. The average shipment value of $70.1K is above the global average of $10.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Itraconazole importers in Switzerland: ACINO PHARMA AG is the largest buyer, accounting for 48.2% ($676.1K) of this market's total imports.
β’ ACINO PHARMA AG β $676.1K (48.2% of Switzerland's total)
Key Insight: Switzerland's per-shipment average of $70.1K (598% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Switzerland is a key market for Itraconazole imports from India.
Top supplier: 4 customers
6 suppliers β 123 countries
Network value: $27.4M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,727 Verified Shipments
285 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists